These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 4316342)

  • 21. Atypical myasthenia gravis. A neurophysiological and pharmacological study.
    Bergmans J; Cleppe D; Diniz P; Rosselle N
    Electromyogr Clin Neurophysiol; 1975 Jul; 15(3):271-7. PubMed ID: 173519
    [No Abstract]   [Full Text] [Related]  

  • 22. Myasthenia gravis and thymoma: paraneoplastic failure of neuromuscular transmission.
    Hohlfeld R
    Lab Invest; 1990 Mar; 62(3):241-3. PubMed ID: 2156108
    [No Abstract]   [Full Text] [Related]  

  • 23. Pseudo plus-minus lid syndrome.
    Bandini F
    Arch Neurol; 2009 May; 66(5):668-9. PubMed ID: 19433671
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of intermittent noninvasive ventilation in anticholinesterase dose adjustment for myasthenic crisis.
    Mishra SK; Krishnappa S; Bhat RR; Badhe A
    Acta Anaesthesiol Taiwan; 2010 Mar; 48(1):53-4. PubMed ID: 20434116
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.
    Riggs JE
    Clin Neuropharmacol; 1982; 5(3):277-92. PubMed ID: 6288236
    [No Abstract]   [Full Text] [Related]  

  • 26. Autoimmune myasthenia gravis in childhood.
    Andrews PI
    Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse interaction between corticosteroid hormones and anticholinesterase drugs.
    Patten BM; Oliver KL; Engel WK
    Trans Am Neurol Assoc; 1973; 98():248-52. PubMed ID: 4784943
    [No Abstract]   [Full Text] [Related]  

  • 29. Adverse drug effects on neuromuscular transmission.
    Howard JF
    Semin Neurol; 1990 Mar; 10(1):89-102. PubMed ID: 2161128
    [No Abstract]   [Full Text] [Related]  

  • 30. Acetylcholinesterase inhibitors in MG: to be or not to be?
    Punga AR; Stålberg E
    Muscle Nerve; 2009 Jun; 39(6):724-8. PubMed ID: 19260048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent evidence on the neuromuscular block in myasthenia gravis.
    Desmedt JE; Borenstein S
    Electroencephalogr Clin Neurophysiol; 1971 Apr; 30(4):366. PubMed ID: 4103546
    [No Abstract]   [Full Text] [Related]  

  • 32. [Single fiber electromyography in myasthenia gravis].
    Huang SR
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Dec; 19(6):345-8. PubMed ID: 3034526
    [No Abstract]   [Full Text] [Related]  

  • 33. The kinetics of transmitter release in myasthenia gravis. I. An electrophysiological analysis of the storage of transmitter.
    Bergmans J; Rosselle N; Verheyen G; Schellens L
    Electromyogr Clin Neurophysiol; 1972; 12(5):443-88. PubMed ID: 4350884
    [No Abstract]   [Full Text] [Related]  

  • 34. Benefit from alternate-day prednisone in myasthenia gravis.
    Warmolts JR; Engel WK
    N Engl J Med; 1972 Jan; 286(1):17-20. PubMed ID: 4331158
    [No Abstract]   [Full Text] [Related]  

  • 35. Myasthenia gravis and myasthenic syndrome: simulation of twitch strength with or without therapy.
    Nigrovic V; Amann A; Bhatt S
    Muscle Nerve; 2005 Dec; 32(6):745-50. PubMed ID: 16094654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathophysiology of myasthenia gravis and the myasthenic syndrome].
    Struppler A; Ruprecht EO
    Anaesthesist; 1971 Jan; 20(1):29-35. PubMed ID: 4322997
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current status of the physiopathology and treatment of myasthenia gravis].
    Vázquez A; Fernández O
    Rev Clin Esp; 1978 May; 149(4):321-6. PubMed ID: 694105
    [No Abstract]   [Full Text] [Related]  

  • 38. Rational therapy of myasthenia gravis.
    Finley JC; Pascuzzi RM
    Semin Neurol; 1990 Mar; 10(1):70-82. PubMed ID: 2189183
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neuromuscular disorders, especially myasthenia].
    Loyning Y
    Tidsskr Nor Laegeforen; 1972 Apr; 92(12):855-8. PubMed ID: 4337652
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mechanism of action of muscle relaxants and its clinical problems].
    Suzuki H
    Masui; 1974 Aug; 23(8):679-92. PubMed ID: 4372420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.